GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » JCL Bioassay Corporation (TSE:2190) » Definitions » Net Margin %

JCL Bioassay (TSE:2190) Net Margin % : 23.15% (As of Sep. 2014)


View and export this data going back to . Start your Free Trial

What is JCL Bioassay Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. JCL Bioassay's Net Income for the three months ended in Sep. 2014 was 円142 Mil. JCL Bioassay's Revenue for the three months ended in Sep. 2014 was 円613 Mil. Therefore, JCL Bioassay's net margin for the quarter that ended in Sep. 2014 was 23.15%.

The historical rank and industry rank for JCL Bioassay's Net Margin % or its related term are showing as below:

TSE:2190' s Net Margin % Range Over the Past 10 Years
Min: -10.01   Med: 0.71   Max: 10.41
Current: 6.67


TSE:2190's Net Margin % is not ranked
in the Biotechnology industry.
Industry Median: -151.78 vs TSE:2190: 6.67

JCL Bioassay Net Margin % Historical Data

The historical data trend for JCL Bioassay's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JCL Bioassay Net Margin % Chart

JCL Bioassay Annual Data
Trend Mar08 Mar09 Mar10 Mar11 Mar12 Mar13 Mar14
Net Margin %
Get a 7-Day Free Trial 0.71 -10.01 -8.82 -6.29 2.84

JCL Bioassay Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.60 18.48 0.96 -26.25 23.15

Competitive Comparison of JCL Bioassay's Net Margin %

For the Biotechnology subindustry, JCL Bioassay's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JCL Bioassay's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, JCL Bioassay's Net Margin % distribution charts can be found below:

* The bar in red indicates where JCL Bioassay's Net Margin % falls into.



JCL Bioassay Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

JCL Bioassay's Net Margin for the fiscal year that ended in Mar. 2014 is calculated as

Net Margin=Net Income (A: Mar. 2014 )/Revenue (A: Mar. 2014 )
=62.788/2207.383
=2.84 %

JCL Bioassay's Net Margin for the quarter that ended in Sep. 2014 is calculated as

Net Margin=Net Income (Q: Sep. 2014 )/Revenue (Q: Sep. 2014 )
=142.043/613.487
=23.15 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


JCL Bioassay  (TSE:2190) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


JCL Bioassay Net Margin % Related Terms

Thank you for viewing the detailed overview of JCL Bioassay's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


JCL Bioassay (TSE:2190) Business Description

Traded in Other Exchanges
N/A
Address
JCL Bioassay Corporation is engaged in providing clinical and non-clinical trial services for pharmaceutical companies.

JCL Bioassay (TSE:2190) Headlines

No Headlines